← All stocks

SUPERNUS PHARMACEUTICALS, INC.

SUPN Net selling
CIK 0001356576 #1815 in the set updated 17 Sep 2026
Bought (120 mo)
$189.98K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$97.56M
$3.53M on a plan · $89.14M straight out of an exercise
Sold at will
$4.90M
20 of 153 sales
Net
−$97.37M
−$4.71M against sales at will

By person

17 insiders · 165 transactions
159×

Jack A. Khattar holds 159 times base salary in stock. $165.52M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Khattar Jack A.
President, CEO
$189.98K (1)
$39.33M (41) scheduled
−$39.14M
3,278,901
5.64%
$165.52M
+28.0%
Bhatt Padmanabh P.
Sr. VP of IP, CSO
$19.25M (44) scheduled
−$19.25M
18,637
0.0321%
$940.80K
−69.8%
PATRICK GREGORY S
Sr. VP Chief Financial Officer
$10.38M (12) scheduled
−$10.38M
44,463
0.0765%
$2.24M
Schwabe Stefan K.F.
Executive Vice President & CMO
$9.89M (5) scheduled
−$9.89M
2,772
0.0048%
$139.93K
0.0%
Vaughn Victor
Sr. VP of Sales & Marketing
$7.79M (10) scheduled
−$7.79M
9,344
0.0161%
$471.69K
0.0%
Mottola Frank
SVP, Chief Tech. Ops. Officer
$2.71M (8) scheduled
−$2.71M
19,544
0.0336%
$986.58K
+99.7%
GEMAYEL GEORGES
Director
$2.35M (6) scheduled
−$2.35M
27,277
0.0469%
$1.38M
NEWHALL CHARLES W III
Director
$2.00M (7) scheduled
−$2.00M
124,119
0.2135%
$6.27M
+37.8%
Hudson Frederick M.
Director
$1.18M (6)
−$1.18M
60,413
0.1039%
$3.05M
+1,108%
Martin Tami Tillotson
Sr. V.P., Regulatory Affairs
$1.18M (7) scheduled
−$1.18M
86,933
0.1496%
$4.39M
−1.8%
DEC TIMOTHY C
Senior Vice-President & CFO
$524.09K (1)
−$524.09K
9,129
0.0157%
$460.83K
+176.5%
Horich William Todd
SVP, Commercial Operations
$483.80K (2)
−$483.80K
0
0.0000%
$0.00
−100.0%
Sensenig Bethany
Director
$455.11K (3) scheduled
−$455.11K
0
0.0000%
$0.00
Rubin Jonathan
SVP, Chief Medical Officer
$36.29K (1) scheduled
−$36.29K
13,979
0.0240%
$705.66K
+465.7%
SIEBERT JOHN M
Director
87,943
0.1513%
$4.44M
+349.5%
Barlow Carrolee
Director
27,045
0.0465%
$1.37M
Nuerge William A.
Director
23,750
0.0409%
$1.20M
0.0%
Insider
Date
Role
Action
Shares
Price
Amount
Khattar Jack A.
23 Aug 2019
President, CEO
Buy
7,200
$26.39
$189.98K

What was left out

Form 4 filings counted 377
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 124
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 4,044,015
Sales filed before the plan box existed 11
History held since 16 Sep 2016